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the technical contract monitor for the Aerospace Medical Research
Laboratory.
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SECTION I
INTRODUCTION
Methylisobutylketone (MIBK) is used as a solvent in a plastic
formulation which, in the pliable manufactured end product form, is
relatively noncombustible in an oxygen-rich environment. This quality
in the finished plastic product makes it a highly useful material for
space cabin equipment such as seat padding.
The manufactured product contains, entrapped in the plastic,
some residual MIBK which will outgas under reduced pressure condi-
tions and may appear as a contaminant in the spacecraft environment.
Industrial experience with MIBK has not shown any adverse
physiological effects on man other than headache or nausea at or
around the industrial Threshold Limit Value (TLV) of 100 ppm. Elkins
(reference 1) reported that exposed workers developed some tolerance
to MIBK during the working week but lost this tolerance over the week-
end. Silverman et al. (reference 2) found that a 100-ppm exposure to
MIBK was acceptable to 12 human volunteers for a 15-minute period
but that 200 ppm was objectionable due to odor intensity. Because high
air concentrations of MIBK have a narcotic action which would affect
human performance, further information about prolonged or continuous
exposure to this chemical was desired. Two-week range-finding
experiments were conducted at 100 ppm and 200 ppm MIBK under con-
tinuous exposure conditions to establish criteria for a subsequent
longer term study. This 90-day study was designed and performed
to evaluate the continuous inhalation toxicity of MIBK under space cabin
conditions.
SECTION II
MATERIALS AND METHODS
ANIMAL EXPOSURE FACILITIES
Animal exposure facilities (references 3 and 4) of the Aerospace
Medical Research Laboratory were used for both the 2-week and the
90-day continuous experiments. The altitude chambers (Thomas Domes)
are capable of operating at pressures between 5 psia (258 mm Hg) and
14. 7 psia (760 mm Hg). They are equipped to operate with either 100%
oxygen, ambient air, or mixtures of these gases over a range of 20% to
100% oxygen in the atmosphere of the chamber. The chambers are
automated to control temperatures at 72 + 5 F and relative humidity
at 50 + 10%. Gas flow through a chamber may be varied from 0 to 125
cfm. A flow rate of 40 cfm maintains the carbon dioxide concentration
below 0. 5% (usual range of 0. 05-0. 10%) when the chamber has a full
load of animals.
EXPERIMENTAL CONDITIONS
The 2-week range-finding experiments were conducted in the
altitude chambers operating in the ambient pressure mode. Air flow
was maintained at 40 cfm and chamber temperature at 72 F. The
absolute pressure was held at 725 mm Hg to seal the chamber and pre-
vent contamination of the surrounding laboratory environment with
MIBK vapor. After completion of the 2-week studies a 90-day continu-
ous exposure study was performed at 260 mm Hg pressure, mixed-gas
conditions. During the latter experiment, the gas flow was maintained
at 40 cfm and temperature was held in the 72 j- 5 F range. The gas
mixture used was 68% O2 - 32% N2 at 5 psia pressure.
CONTAMINANT GENERATION AND MONITORING OF CHAMBER
CONCENTRATIONS
The MIBK used in these studies was purchased from the Matheson
Company, Incorporated, East Rutherford, New Jersey. The liquid was
introduced into an all glass vaporizing unit by means of a dual syringe
pump from a large reservoir. Dry air flowing through the heated vapor-
izer carried the MIBK vapor through a flowmeter and metering valve
system into the chamber air supply duct. The stainless steel tubing
between the vaporizer and metering valve was heated to prevent re-
condensation of the MIBK. Heating was not necessary after dilution in
the chamber air supply duct.
A gas chromatographic procedure was developed for contaminant
monitoring on a semi-continuous basis. Air samples were taken from a
position in the chamber just above the breathing zone of the dogs and con-
tinuously pumped to the analyzer system where an automatic sampling
valve took samples every 5 minutes. The samples were introduced
directly into the gas chromatograph sample inlet.
The MIBK in the gas sample was separated on a 10-inch column
of Porapak Q operated at 190 C and detected with a flame ionization
detector. The retention time of MIBK in this system was 1. 5 minutes
which allowed convenient sampling at 5 minute intervals. MIBK vapor
calibration standards made up in Mylar® bags were used daily and a
variation in detector response of + 5% was found. The variation from
one bag to another when run the same day was approximately 2%.
SECTION III
EXPERIMENTAL RESULTS
RESULTS OF RANGE-FINDING STUDIES
Rats, mice, dogs and monkeys were continuously exposed to a
mean concentration of 100 ppm MIBK for 2 weeks at ambient conditions
in the Thomas Domes. Test animals included 4 monkeys, 8 dogs, 40
mice, and 50 rats. As controls, 3 monkeys, 4 dogs, 20 mice, and 25
rats were placed in another Thomas Dome under the same conditions
with the exception of contaminant. One monkey in each group had
cortical electrodes implanted for evaluation of central nervous system
(CNS) effects.
Test programs were designed to evaluate the inhalation effects
of the MIBK exposure as outlined below:
Preexposure Tests
1. Body Weight
2. Clinical Chemistry
3. Hematology
4. EEC
During Exposure Tests
1. Spontaneous Activity Measurement
2. Symptomatology
3. Mortality Response
Postexposure Tests
1. Body Weight
2. Organ to Body Weight Ratios
3. EEC
4. Clinical Chemistry
-5. Hematology
6. Pathology
7. Blood pH and Gases
There were no signs of toxic response during exposure. At the
end of the 2-week exposure period there was no difference in cortical
activity between the exposed and control monkey nor were any signifi-
cant differences observed in hematologic or clinical chemistry mea-
surements for either dogs or monkeys. Gross pathologic examination
of tissues from both exposed and control animals failed to reveal any
apparent differences. Blood gas measurements made on dogs did not
show any effects attributable to MIBK exposure. Tissue specimens
were collected at necropsy and examined microscopically.
Organ weight and organ to body weight ratios were evaluated
and the kidneys found significantly heavier in the rats exposed to MIBK
(see table I).
TABLE I
Effect of 2-Week Exposure to Inhaled MethylisobutyBcetone
(100 ppm) on Organ Weights of Albino Rats
EXPOSED
N
x" Organ Wt.
x Ratios2
N
x" Organ Wt.
x Ratios2
Spleen Kidneys
25
0.9
0.417
CONTROLS
23 24
1.3 8.4
0. 569 3. 753
50
0.8
0.353
25
0.8
0.346
50
1.7**
0.729**
25
1.5
0.670
grams
2
 grams/100 grams body weight
** significantly different from controls at 0. 01 level
Since the only preliminary indication of a toxic response to the
2 -week inhalation exposure of 100 ppm MIBK was its effect on rat kidney
weight and a slight indication of depressed growth in rats, a second
2 -week exposure was conducted at an atmospheric concentration of 200
ppm MIBK, and the same biological measurements and examinations
were performed.
The animals exposed to 200 ppm MIBK showed no outward toxic
effects that could be attributed to the 2 -week exposure. Again the only
effect observed was on rats in which both the liver and kidney weights
were statistically different from those in the control group as shown in
table II.
TABLE II
Effect of 2-Week Exposure to Inhaled Methylisobutylketone
(200 ppm) on Organ Weights of Albino Rats
N
x Organ Wt.
x Ratios2
N
x Organ Wt.
x Ratios2
EXPOSED
Lung Liver
46
1.3
0.499
Spleen
50
0.8
50
0.9
0.343
50
9.0**
3.445** 0.291
CONTROLS
42 50 50
1.3 8.2 0.8
0.510 3.198 0.303
Kidneys
50
1.8**
0.694**
50
1.5
0.582
grams
2
 grams/100 grams body weight
* significant at the 0. 05 level only
** significant at the 0. 01 level
From the data obtained in this experiment and observations
made from the previous MIBK inhalation study, the kidney appeared to
be the organ primarily affected by the exposure to MIBK. Physical
properties of MIBK (bp 117 C) suggest that the kidney may be the major
route of excretion. The persistent finding of significant changes in
kidney weights and kidney to body weight ratios in the rat indicated that
MIBK exposure caused kidney changes. Histopathologic examination
of the rat kidney revealed toxic nephrosis in the proximal tubules of
MIBK exposed rats at both exposure levels.
Based on these results, the 100 ppm MIBK exposure level was
selected for the continuous 90-day study under simulated space cabin
conditions.
90-DAY CONTINUOUS EXPOSURES
The experimental animal species selected for prolonged continu-
ous exposure included dogs, rats and monkeys. All animals used were
males. The numbers of animals used in the test and control groups
were as follows:
Albino Rats 100 - Wistar Strain
Dogs 8 - Beagle Variety
Monkeys 2 - Macaca mulatta
Two additional monkeys were placed in each group for special studies
by other laboratories. These monkeys were surgically prepared with
exteriorized kidneys for repetitive punch biopsy. The biopsy material
was prepared for electron microscopic studies and submitted to the
Albany Medical Center at the request of the National Aeronautics and
Space Administration (NASA). The results of these examinations were
not available when this report was prepared.
Experimental Conditions
The test animals were exposed to 410 mg/M^ MIBK vapor (100
millimole/25 M^) for a period of 90 days in an altitude chamber operated
at 5 psia pressure and a 68% C-2 - 32% N2 gas mixture. The control
group of animals was maintained in a separate altitude chamber, under
identical environmental conditions, except that no MIBK was present.
Clinical Tests of Dogs and Monkeys
All dogs were examined biweekly, including the month prior to
initiation of the experiment. At the time of each examination, the dogs
were weighed and blood samples were taken for hematology and a battery
of clinical chemistry tests.
Liver function tests (bromsulphalein [BSP] dye retention) were
performed preexposure and immediately postexposure. Serum acid
phosphatase and serum glucuronide determinations were done preexpo-
sure and at 30 and 60 days.
At termination, two dogs from each group were transferred to
the postexposure holding room for 60 days to determine reversibility
of effects should any lesions be found. The remaining six dogs in each
group were killed, examined grossly, and samples of liver, brain, kid-
ney, heart, lung, spleen, and endocrine glands were taken for histological
evaluation.
Tests on Rats
Rats were weighed preexposure and biweekly during the exposure
period to determine growth rate. Two rats from each group were necrop-
sied at weekly intervals for 3 weeks and then at biweekly intervals there-
after. After 2 weeks exposure, 10 rats were removed from each chamber
and necropsied in groups of 2 at biweekly intervals to determine reversi-
bility of the kidney lesion as seen in the preliminary experiments. At
termination of the experiment, 10 rats from each group were removed
and saved for serial sacrifice for reversibility studies, 10 were sub-
mitted to histopathology, and the remaining rats were necropsied and
the visceral organs weighed for determination of organ to body weight
ratios.
RESULTS OF LARGE ANIMAL EXPOSURES
Clinical Measurements
The results of clinical chemistry and hematology tests on dogs
and monkeys did not reveal any biologically significant differences be-
tween the exposed animals and their controls. The biweekly mean
values of these determinations are shown in table III for dogs and in
table IV for monkeys.
Serum acid phosphatase levels determined on dogs and monkeys
before exposure and at various intervals during exposure are shown in
table V. Although some increase over baseline level was seen in the
animals during exposure, the values were not different from those of
control animals.
The results of serum glucuronidase activity measurements are
shown in table VI. The difference between the exposed and control
monkeys is relatively large but remains fairly constant throughout the
experiment and is not related to the MIBK exposure.
Liver function tests were performed on dogs before and after
90-day exposure to MIBK. Bromsulphalein (4 mg/kg) was given intra-
venously and the dye concentration measured in blood 15 minutes later.
There were no significant differences between the exposed and control
animals as shown in table VII.
Histopathology:
)ogs
Tissue sections from heart, lung, brain, liver, spleen, kidney,
adrenals and pituitary glands were examined in both exposed and control
animals. No differences were observed between the two groups. Since
the range-finding experiments had shown the kidney to be the target
organ, the routine hematoxylin and eosin stained sections were supple-
mented with thin sections (1 ju) stained with toluidine blue, methylene
blue and oil red-O. In the thin sections, hyaline droplets were noted
in one exposed and in one control dog while the oil-red O showed fat
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TABLE III
Clinical Laboratory Results on MIBK
Exposed and Control Dogs
Weeks
Exposed
-1
1
3
5
7
9
11
13
Weeks
Exposed
-1
1
3
5
7
9
11
13
HCT
(vol %)
Exposed
45
43
47
44
47
47
47
47
Control
44
46
44
43
45
48
46
47
WBC
(thousands)
Exposed
10.1
16.0
13.9
11.7
11.8
10.9
9.6
12.5
Control
10.4
13.7
16.2
13.6
13.2
11.3
13.4
13.2
HGB
(grams %)
Exposed
15.3
14.6
15.6
15.2
15.6
15.5
15.5
15.4
Control
14.8
14.9
15.5
14.9
14.7
16.0
14.7
15.4
Sodium
(meq/liter)
Exposed
149
144
149
150
146
151
148
152
Control
148
146
149
146
145
147
150
151
RBC
(millions)
Exposed
6.8
6.4
6.6
6.7
6.8
5.3
6.8
5.7
Control
6.8
6.5
5.9
6.5
6.5
7.1
6.7
5.8
Potassium
(meq/liter)
Exposed
4.7
4.5
4.8
4.9
4.8
4.4
4.6
5.0
Control
4.5
4.4
4.5
4.4
4.5
4.4
4.5
4.6
TABLE III -- CONTINUED
Weeks
Exposed
-1
I
3
5
7
9
11
13
Weeks
Exposed
-1
1
3
5
7
9
11
13
Cholesterol
(mg %)
Exposed
159
—
151
153
159
153
149
149
Control
130
—
131
144
148
151
154
144
Total Bilirubin
(mg%)
Exposed
0.2
0.2
0.3
0.2
0.2
0.2
0.3
0. 1
Control
0.3
0.2
0.3
0.2
0.2
0.2
0.3
0.1
Calcium
(mg%)
Exposed
10.3
10.5
10.3
10.6
10.6
10.5
10.5
10.6
Control
10.2
10.3
10.3
10.2
10.3
10.4
10.3
10.6
Albumin
(grams %)
Exposed
3.6
3.6
3.5
3.6
3.6
3.6
3.7
3.8
Control
3.6
3.8
3.4
3.6
3.7
3.7
3.8
3.6
Total Phosphorus
(mg%)
Exposed
4.6
4.8
4.8
4.8
5.0
4.5
3.9
5.0
Control
4.8
4.6
4.6
5.3
4.9
4.7
4.5
4.9
Total Protein
(grams %)
Exposed
5.8
6.1
6.2
6.2
6.2
6.3
6.3
6.3
Control
5.9
6.4
6.1
6.2
6.2
6.4
6.3
6.4
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TABLE III -- CONCLUDED
Weeks
Exposed
-1
1
3
5
7
9
11
13
Weeks
Exposed
-1
1
3
5
7
9
11
13
Uric Acid
(mg%)
Exposed
0.7
0.7
0.6
0.5
0.6
0.4
0.5
0.4
Control
0.6
0.6
0.7
0.5
0.6
0.4
0.6
0.4
Alkaline Phosphatase
(KA units)
Exposed
22
22
13
13
10
10
11
11
Control
14
19
14
12
10
10
11
12
. BUN
(mg %)
Exposed
13
14
12
13
12
11
13
10
Control
13
12
12
13
14
14
13
12
Creatinine
(mg %)
Exposed
0.8
0.6
0.6
0.7
0.7
0.6
0.7
0.6
Control
0.8
0.7
0.6
0.6
0.8
0.7
0.7
0.6
Glucose
(mg%)
Exposed
103
86
96
104
102
101
101
98
Control
104
91
96
101
106
114
101
108
Chloride
(meq/liter)
Exposed
115
115
116
114
112
118
117
116
Control
114
115
112
114
112
117
116
112
11
TABLE IV
Clinical Laboratory Results on MIBK
Exposed and Control Monkeys
Weeks
Exposed
-1
1
3
5
7
9
11
13
Weeks
Exposed
-1
1
3
5
7
9
11
13
HCT
(vol %)
Exposed
39
40
40
35
38
36
36
37
Control
37
41
36
39
38
38
39
40
WBC
(thousands)
Exposed
9.4
6.8
8.0
7.2
5.8
6.2
5.6
6.7
Control
8.6
5.2
4.8
4.8
5.4
5.1
5.1
5.3
HGB
(grams %)
Exposed Control
12.1 12.2
12.0 12.2
12.3 12.5
11.4 12.1
11.8 11.9
11.4 12.3
11.3 11.4
11.1 12.0
Sodium
(meq/liter)
Exposed Control
151 151
148 150
153 151
149 146
150 148
152 151
147 154
155 151
RBC
(millions)
Exposed Control
5. 4 5. 4
5. 4 5. 4
5. 2 5. 4
5. 0 5. 3
4. 9 5. 4
4. 7 5. 3
4. 9 5. 4
4. 8 5. 0
Potassium
(meq/liter)
Exposed Control
4. 3 3. 9
4.2 4.6
4. 5 4. 1
4. 3 4. 1
5.1 4.5
4. 5 4. 5
4. 6 3. 8
4. 8 4. 4
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TABLE IV -- CONTINUED
Weeks
Exposed
-1
1
3
5
7
9
11
13
Weeks
Exposed
-1
1
3
5
7
9
11
13
Cholesterol
(mg%)
Exposed
198
—
225
210
198
218
188
208
Control
168
—
188
205
188
195
215
188
Total BilirubLn
(mg %)
Exposed
0.2
0.3
0.3
0.4
0.3
0.3
0.3
0.1
Control
0.2
0.4
0.4
0.3
0.4
0.4
0.4
0.1
Calcium
(mg %)
Exposed
10.9
10.8
10.4
10.2
10.6
10.2
10.2
10.8
Control
10.8
11.0
10.6
10.6
10.4
10.8
10.6
10.7
Albumin
(grams %)
Exposed
4.7
5.1
5.0
4.7
4.8
5.1
5.1
5.3
Control
4.7
5.1
5.1
5.1
5.0
5.0
5.2
5.0
Total Phosphorus
(mg %)
Exposed
5.9
7.6
8.1
7.7
8.4
7.4
6.1
7.0
Control
4.2
7.5
6.8
7.4
8.0
6.4
7.6
6.0
Total Protein
(grams %)
Exposed
7.9
8.1
8.1
7.8
7.7
7.8
7.5
8.0
Control
7.6
7.9
7.9
7.8
7.6
7.7
7.7
7.7
13
TABLE IV -- CONCLUDED
Weeks
Exposed
-1
1
3
5
7
9
11
13
Weeks
Exposed
-1
1
3
5
7
9
11
13
Uric Acid
(mg %)
Exposed
0.5
0.6
0,6
0.4
0.5
0.3
0.3
0.4
Control
0.5
0.5
0.5
0.5
0.4
0.4
0.4
0.3
Alkaline Phosphatase
(KA units)
Exposed
64
53
50
54
54
56
51
47
Control
47
50
44
45
49
45
48
45
BUN
(mg %)
Exposed
22
15
17
20
18
18
18
16
Control
18
17
18
17
22
14
22
13
Creatinine
(mg %)
Exposed
1.2
0.9
0.9
1.3
1.2
1.1
1.1
1.0
Control
1.3
1.1
1.0
1.4
1.3
1.2
1.2
0.9
Glucose
(mg %)
Exposed
90
85
93
95
80
85
70
78
Control
98
65
80
80
75
83
78
88
Chloride
(meq/liter)
Exposed
115
113
112
111
110
115
108
114
Control
116
110
112
110
110
116
111
111
14
TABLE V
Serum Acid Phosphatase Levels* in Animals Continuously
Exposed to 410 mg/M3 MIBK
DOGS
Controls (8)
Total
Prostatic
Re sidual
Baseline
5.4 (3.1-8.2)
2.1 (1.3-2.7)
3.4 (1.8-5.5)
30 Days
5.0 (3.8-6.5)
2.2 (1.4-3.2)
2.9 (2.0-3.8)
60 Days
5.8 (4.2-8.3)
2.3 (1.9-3.1)
3.4 (1.6-5.3)
Exposed (8)
Total
Prostatic
Residual
4.4 (3.6-5.1)
1.9 (1.5-2.3)
2.5 (1.8-3.1)
5.3 (3.7-9.0)
2.2 (1.7-3.0)
3.2 (1.4-6.6)
5.3 (4.1-6.9)
2.3 (1.8-3.0)
2.9 (2.0-4.5)
Controls (2)
Total
Prostatic
Residual
MONKEYS
20.8 (20.5,21.2)
5.5 (5.4,5.6)
15.3 (14.9,15.8)
20.9 (19.2,22.7)
5.5 (3.9,7.2)
15. 4 (15. 3, 15. 5)
20.2 (19.5,21.0)
5.3 (5.0,5.7)
15.0 (14.5,15.3)
Exposed (2)
Total
Prostatic
Residual
16.1(15.6,16.6) 19.4(17.8,21.0) 19.6(16.2,23.0)
4.4(3 .7 ,5 .2) 5.5(5.4,5.7) 5. 6. (5. 3, 5. 9)
11.7(11.4,11.9) 13.8(12.4,25.3) 14.0(10.9,17.1)
The enzyme activity is measured in International Units (uM p-nitrophenol
formed per minute per liter serum @ 37 C, pH 4. 8).
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TABLE VII
Results of BSP Liver Function Tests on Animals Continuously
Exposed to 410 mg/M3 MIBK for 90 Days
Percent Dye Retention
Control Dog Number 0 Day 90 Day
M-48
M-64
N-10
M-76
N-08
N-06
M-42
M-14
Exposed Dog Number
N-14
M-66
M-70
M-44
M-26
.. M-34
M-30
M-32
6.5
8.0
.9.0
5.5
8.5
8.0
8.5
10.0
11.0
8.0
7.0
11.0
8.0
7.0
7.5
8.5
4.5
8.0
5.0
10.0
0.5
10.0
5.5
11.5
11.0
7.5
7.0
12.5
3.2
6.0
7.0
8.0
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scattered in a few tubules at the corticomedullary junction in exposed
dogs. The latter finding is commonly seen in untreated dogs. The
methylene blue stains showed no differences between the exposed and
control animals.
Monkeys
The two monkeys in each group without translocated kidneys
were examined histologically. The same tissues as examined in dogs
were screened with H and E stains. One of the two exposed monkeys
exhibited focal chronic inflammation of the kidney. No other pathologi-
cal changes were noted.
RESULTS OF RAT EXPOSURES
Growth
The growth rates (measured biweekly) of both the exposed and
control groups of rats are shown in figure 1. There was no significant
effect upon the growth rate as a result of continuous exposure to MIBK
for 90 days.
Organ Weight
The effect of exposure to MIBK on albino rat organ weights and
organ to body weight ratios is shown in table VIII. There is a statisti-
cally significant difference in the liver and kidney weights of the exposed
animals with a corresponding increase in organ to body weight ratios for
these tissues.
Histopathology
No significant pathologic changes were seen in any of the organs
examined from control rats. All exposed rats, however, showed hyaline
droplet degeneration of the proximal tubules with occasional foci of tubu-
lar necrosis upon completion of the 90-day exposure to 410 mg MIBK/M3.
Rats removed from exposure after 15, 22, 28, 71 and 85 days also showed
the same changes in kidney tubules. Thus, as few as 15 days of exposure
to the experimental condition produced some pathologic change in kidney
tissue. A trend toward a linear progression of hyaline droplet degenera-
tion over the time period of exposure was observed, although individual
animals did not all follow this pattern. Also of note, hyaline droplets
tended to be larger with time, possibly as a result of coalescence of the
smaller droplets.
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Figure 1
Growth Rate of Albino Rats Continuously
Exposed to MIBK for 90 Days
500-
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TABLE VIII
Effect of 90-Day Continuous Exposure to MIBK on Organ and
Organ to Body Weight Ratios in Albino Rats
Organ Weight
(grams)
Ratios
(gram/100 grams body weight)
Heart
Lung
Liver
Spleen
Kidney
Test
N = 56
1.3
1.5
10. 8**
0.7
3.1**
Control
N = 55
1.3
1.5
9.9
0.7
2.6
Test
N = 56
0.302
0.352
2.477**
0.159
0.713**
Control
N = 56
0.306
0.359
2.305
0. 160
0. 604
significant at the 0. 01 level
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Although rat liver weights and liver to body weight ratios showed
a statistically significant increase in exposed animals, there were no
pathologic changes associated with this increase.
Rats removed for reversibility studies after 15-day exposure
to MIBK revealed a gradual reversion of kidney tubular damage with
time which appeared to be completely reversed in those rats held for
60 days postexposure. The rats retained and serially killed for rever-
sibility studies after 90-day exposure also exhibited recovery from the
MIBK induced lesion but not as rapidly as those exposed for a shorter
period.
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SECTION IV
CONCLUSIONS
Animals exposed continuously to 410 mg/M^ MIBK for 90 days
under space cabin environmental conditions were not adversely affected,
with the exception of albino rats. Hyaline droplet tubular nephrosis
developed in albino rats under the experimental conditions used but did
not result in debilitation or death. The lesions developed within 2 weeks
of exposure and were reversible upon removal from the MIBK environ-
ment even after 90-day exposure. Based on the results of these experi-
ments in space cabin environments, concentrations of MIBK up to 410
mg/M^ (100 ppm equivalent) should be tolerable for man for the time
period investigated. Furthermore, these data indicate that the 60-
minute emergency limit of 100 ppm and the 90- and 1000-day provisional
limit of 20 ppm as established by the Space Science Board, NAS/NRC, in
1968 contain a wide margin of safety.
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